French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
The company BAYER DIAGNOSTICS withdraws from the market batches 1C051 (per.28.02.03), 1E035 (per 31.03.03) and 1F045 (per.31.03.03) of the in vitro diagnostic medical device called: 654 CAL - PAK / reference A473605000 following the risk of obtaining results lowered from 0.10 to 0.12 mmol / l for lithium.